New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 25, 2012
06:01 EDTACTG, VARAcacia Research unit enters into settlement agreement with Varian Medical
Acacia Research Corporation (ACTG) announced that its Brain Life LLC subsidiary has entered into a settlement agreement with Varian Medical Systems (VAR). The agreement resolves litigation that was pending in the United States District Court for the Southern District of California.
News For ACTG;VAR From The Last 14 Days
Check below for free stories on ACTG;VAR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 17, 2013
06:00 EDTACTGAcacia Research enters into license, settlement agreement with Mitel Networks
Subscribe for More Information
May 14, 2013
12:19 EDTVARVarian Medical reaffirms Q3, FY13 outlooks during mid-year view
Subscribe for More Information
06:02 EDTACTGAcacia Research subsidiary enters into agreement with BAIS
Acacia Research announced that its Brandywine Communications Technologies subsidiary has entered into a license and settlement agreement with BAIS, dba Bay Area Internet Solutions. This agreement resolves patent litigation that was pending in the United States District Court for the Central District of California.
May 9, 2013
06:02 EDTACTGAcacia Research subsidiary enters into license agreement with Office Depot
Subscribe for More Information
06:00 EDTACTGAcacia Research subsidiary enters into settlement agreement with Shutterfly
Subscribe for More Information
May 7, 2013
06:10 EDTACTGAcacia Research subsidiary enters into license settlement agreement
Acacia Research announced that its Unified Messaging Solutions subsidiary has entered into a license and settlement agreement with Capital One Financial Corporation and Ing Direct. This agreement resolves patent litigation that was pending in the U.S. District Court for the Western District of Texas.

Sign up for a free trial to see the rest of the stories you've been missing.